Strong Third Quarter 2009
> Sales USD 84 million
> Strong prosthetics sales, growing 11%
> EBITDA margin 23%
> Net profit 7% of sales
> Second generation of RHEO KNEE extremely well received
> GPO contract in the US
> Listing on NASDAQ OMX Copenhagen
Jon Sigurdsson, President & CEO, comments:
“We are quite satisfied with the results for the quarter. Our business continues to be successful and profitable. Prosthetics sales exceeded our expectations, and recent product upgrades and the new generation of RHEO KNEE have been well received by the market. This further establishes the acceptance of the Bionic products. Sales of bracing and supports products are stabilizing and we are confident that we will see a turnaround in sales in this segment in the coming quarters.”
